HKBU develops new Chinese medicine formula for Alzheimer’s disease
Hong Kong Baptist University's (HKBU) School of Chinese Medicine researchers have developed a Chinese medicine formula named NeuroDefend.
The new formula offers a potential novel...
Covid breakthrough: Baricitinib plus remdesivir show promising results in treating Corona infection
Covid treatment is no more a dream. In a relif to those who are waiting for Covid-19 medicine, it has emerged that combination of...
BAT moves Covid candidate vaccine towards Phase I human clinical trials
BAT has announced plans to commence a Phase I first-time-in-human study of its Covid-19 vaccine candidate.
The announcement by BAT's US Bio-tech arm, Kentucky BioProcessing...
Kinetic unveils UVC light-based sanitiser that kills 99.9% of coronavirus in 15 minutes
Kinetic Communications Ltd; a member of the Kinetic Group, has introduced 'UV WARRIOR', a portable disinfector that 'sanitises all daily objects and any room...
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease program
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...
Women’s reproductive healthcare gets boost with home blood-testing kit for fertility
Women's fertility issues received a boost, as health start-up Yesmom announced the launch of Asia's first at-home blood testing kits for female fertility, designed...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
Piramal Pharma Solutions on expansion mode, invests ~$32 Million
Piramal Pharma Solutions, a Piramal Pharma Limited business and a leading Contract Development and Manufacturing Organization (CDMO), has revealed its plans to expand its...
Lilly’s Bamlanivimab to be used as Covid-19 treatment
Bamlanivimab (LY-CoV555), a neutralising antibody emerged from collaboration between Lilly and Vancouver-based AbCellera, has been given authorisation by Health Canada, under the Interim Order...
Persavita to test its natural health product in Covid-19
Persavita is gearing up for a clinical trial to test its experimental natural health product in Covid-19.
The company is gearing up to test this...
